CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 740-743, March 2005
© 2005 American Association for Cancer Research

Short Communication

A Prospective Study of Dietary Folate Intake and Risk of Colorectal Cancer: Modification by Caffeine Intake and Cigarette Smoking

Susanna C. Larsson1, Edward Giovannucci2,3 and Alicja Wolk1

1 Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2 Departments of Nutrition and Epidemiology, Harvard School of Public Health; and 3 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Susanna C. Larsson, Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 12, P.O. Box 210, SE-17177 Stockholm, Sweden. Phone: 46-8-52486059; Fax: 46-8-304571. E-mail: susanna.larsson{at}imm.ki.se


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Epidemiologic evidence indicates an inverse association of folate intake with risk of colorectal cancer, but whether this association is modified by intake of caffeine (in coffee and tea) or cigarette smoking—factors that possibly interfere with folate—has not been studied. Thus, we examined whether the association between dietary folate intake and incidence of colorectal cancer is modified by caffeine intake and smoking. Cox proportional hazards modeling was used to estimate rate ratios relating dietary folate intake to colorectal cancer incidence among 61,433 women ages 40 to 75 years at recruitment into the Swedish Mammography Cohort in 1987 to 1990. From March 1987 through June 2004, a total of 805 incident cases of colorectal cancer were diagnosed. After controlling for age and other potential confounders, we observed an inverse association between dietary folate intake and risk of colon cancer (rate ratio for the highest versus the lowest quintile, 0.61; 95% confidence interval, 0.41-0.91; Ptrend = 0.02), but not of rectal cancer (rate ratio, 0.93; 95% confidence interval, 0.55-1.56; Ptrend = 0.97). The inverse association between dietary folate intake and colon cancer risk was most pronounced among smokers (Pinteraction = 0.03). We found no apparent modification of risk by caffeine intake. Findings from this population-based cohort study support an inverse association between dietary folate intake and risk of colon cancer and suggest that smokers might benefit most from a high dietary folate intake.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Evidence is accumulating that folate deficiency is implicated in carcinogenesis, particularly in rapidly proliferative tissues, such as the colorectal mucosa (1, 2). Folate is an essential cofactor for the de novo biosynthesis of nucleotides needed for DNA synthesis and plays a crucial role in DNA methylation, stability and integrity, and repair (1). Folate deficiency may cause defective DNA repair (3) and chromosomal fragile site expression (4), leading to chromosomal breaks (5) and micronucleus formation (4), thus conceivably increasing the risk of colorectal cancer.

Caffeine and theophylline found in coffee and tea have been shown to enhance fragile site expression induced by folate restriction (6, 7). MacGregor et al. (8) reported that folate deficiency causes cytogenetic damage in mice and that caffeine acts synergistically with inadequate folate status to augment this damage. Additionally, consumption of coffee and tea has been directly related to chromosome fragility (9) and chromosomal damage (10) in peripheral lymphocytes and erythrocytes.

Cigarette smoking may increase folate requirements by interfering with folate utilization and/or metabolism (11, 12). It has consistently been shown that smokers have lower circulating folate concentrations than nonsmokers (9, 12, 13). Smoking has been related to higher frequency of cells with chromosome aberrations (9), elevated micronucleus frequency (10), and increased chromosome fragility (14, 15).

Given the widespread consumption of caffeinated beverages, including coffee and tea (16), and high prevalence of cigarette smoking, knowledge about the interplay between these factors and folate intake in predicting the risk of colorectal cancer is of great public health importance. Therefore, in the present study, we analyzed data from a large population-based prospective cohort of Swedish women—a population with a relatively low intake of folate (fortification of cereals and flours are not mandatory) and with the highest per capita caffeine intake in the world (16)—to examine whether the association between dietary folate intake (i.e., folate from food sources) and risk of colorectal cancer is modified by intake of caffeine (in coffee and tea) and smoking.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Study Cohort
The Swedish Mammography Cohort was established between 1987 and 1990 when 66,651 women in Uppsala and Västmanland counties, central Sweden, ages 40 to 75 years (74% of the source population), completed a mailed questionnaire about their diet, weight, height, and educational level. A new questionnaire sent to all surviving participants in 1997 also elicited information on physical activity, cigarette smoking, family history of colorectal cancer, and the use of dietary supplements, aspirin, and hormone replacement therapy.

Women were excluded at baseline if they had an erroneous National Registration Number, reported an extreme energy intake (i.e., three SDs below or above the mean value for log-transformed energy), or if they had a cancer diagnosis (except nonmelanoma skin cancer) before recruitment. After these exclusions, 61,433 women were included and comprised the final population for analysis. The ethical committees at the Karolinska Institutet (Stockholm, Sweden) and the Uppsala University Hospital (Uppsala, Sweden) approved this study.

Assessment of Dietary Intake
At baseline, participants completed a self-administered food-frequency questionnaire that sought information on the average frequency of consumption of 67 common foods during the past 6 months. For each participant, we computed intake of nutrients by multiplying the consumption frequency of each food by the nutrient content in age-specific servings. We obtained data on food composition from the Swedish National Food Administration database (17). All nutrient values were energy-adjusted by using the residual approach (18).

To evaluate the validity of the food-frequency questionnaire, we compared nutrient intake estimated from the food-frequency questionnaire in a subgroup of 129 randomly chosen women from the cohort with their mean intake from four 1-week (3-4 months apart) diet records. Pearson correlation coefficients between the two instruments were 0.5 for dietary folate, 0.6 for coffee, 0.8 for tea, and 0.9 for alcohol. The mean daily dietary folate intake, as estimated from the diet records, was 211 µg (SD = 61 µg).

Ascertainment of Cases and Follow-up
We identified incident colorectal cancer cases that occurred in the cohort by linkage with the National Swedish Cancer Registry and the Regional Cancer Registry in the study area. These registries are estimated to be 98% complete (19). Colon cancers were defined as those occurring above the peritoneal delineation of the abdominal cavity, and rectal cancers were those occurring below this delineation. Proximal colon cancers were defined as tumors occurring from the cecum through the splenic flexure, and distal colon cancers were defined as tumors in the descending and sigmoid colon. Ascertainment of deaths and the date when a participant moved out from the study area were accomplished through matching with the Swedish Death Registry and the Swedish Population Registry.

Statistical Analysis
Each woman accrued follow-up time from the date of her entry to the cohort until the first of any of following: the date of a diagnosis of colon or rectal cancer, the date of death, the date of migration out of the study area, or June 30, 2004. We categorized women into quintiles according to dietary folate intake and computed incidence rates by dividing the number of incident cases by person-years of follow-up in each quintile. The rate ratios (RR) were computed as the rate in a particular quintile of dietary folate intake divided by that in the lowest quintile. The data conformed to the proportional hazards assumptions, and we used Cox proportional hazards models with age in days as the underlying time variable to estimate RR with 95% confidence intervals (CI). We also applied a restricted cubic spline Cox proportional hazards modeling approach (using five knots) to flexibly model the association of dietary folate intake with risk of colorectal cancer, avoiding linearity assumptions (20). Multivariate models were simultaneously adjusted for age, body mass index, educational level, and intakes of red meat, total energy, saturated fat, methionine, vitamin B-6, ß-carotene, calcium, and cereal fiber. Tests for linear trend across increasing categories of dietary folate intake were conducted by using the median value for each category as a continuous variable.

We did analyses stratified by caffeine intake (categorized into tertiles) and smoking (never smoker, ever smoker <10 years, and ever smoker ≥10 years) to examine whether the association of dietary folate intake with risk of colorectal cancer was modified by these factors. Analyses stratified by smoking were based on a subcohort of 38,286 women who responded to the 1997 questionnaire and for whom complete information on smoking status and duration was available. To test for statistical interaction, we entered into the multivariate models cross-product terms for dietary folate intake (as a continuous variable) and caffeine intake and smoking (status and duration) along with the main-effect terms for each. All analyses were conducted with SAS statistical software (version 8.2; SAS Institute, Cary, NC). All reported P values were based on two-sided tests.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Among 61,433 women followed up for a mean of 14.8 years (911,042 person-years), a total of 805 incident colorectal cancer cases occurred, including 547 colon cancers (249 proximal colon, 170 distal colon, and 128 at an unspecified site in the colon) and 252 rectal cancers; six cases were diagnosed with both colon and rectal cancer.

The mean (±SD) energy-adjusted daily dietary folate intake (i.e., folate from food sources) in the cohort, as estimated from the food-frequency questionnaire, was 183 µg (±43.5 µg). Compared with women with a low dietary folate intake, women with higher intakes were slightly older, were less likely to be smokers, were more likely to have a post-secondary education, and had higher intakes of vitamin B-6, ß-carotene, calcium, and cereal fiber but had a lower intake of saturated fat (Table 1). Dietary folate intake was not appreciably related to body mass index and intakes of energy, methionine, caffeine, and red meat.


View this table:
[in this window]
[in a new window]
  		Table 1. Baseline characteristics of the cohort according to quintiles of dietary folate intake

 
We observed an inverse, albeit not statistically significant, association between dietary folate intake and risk of colorectal cancer (Table 2). The multivariate RR for women in the top quintile of dietary folate intake compared with those in the bottom quintile was 0.80 (95% CI, 0.60-1.06). In analyses by subsite in the colorectum, there was a statistically significant inverse association of dietary folate intake with risk of colon cancer (RR for the highest versus the lowest quintile, 0.61; 95% CI, 0.41-0.91), but not of rectal cancer (RR, 0.93; 95% CI, 0.55-1.56). The decreased risk was somewhat stronger for proximal colon than for distal colon cancer (Table 2).


View this table:
[in this window]
[in a new window]
  		Table 2. Rate ratio of colorectal cancer according to dietary folate intake

 
Restricted cubic spline regression analysis indicated a dose-response relationship between dietary folate intake and risk of colon cancer (Fig. 1). Each daily increment of 100 µg dietary folate intake corresponded to a 34% reduction in colon cancer risk (RR, 0.66; 95% CI, 0.48-0.92). The inverse association of dietary folate intake with colon cancer risk persisted after additional adjustment for consumption of fruits and vegetables (RR for each 100 µg/d increase of dietary folate intake, 0.69; 95% CI, 0.48-0.98) and did not change materially in a secondary analysis (using data from the 1997 follow-up questionnaire) that was further adjusted for family history of colorectal cancer, cigarette smoking, physical activity, and use of aspirin and hormone replacement therapy (RR, 0.67; 95% CI, 0.48-0.92). Also, exclusion of women who reported use of vitamin supplements containing folic acid (i.e., multivitamins, B-vitamins, and separate folic acid supplements) in 1997 yielded virtually the same results (RR, 0.69; 95% CI, 0.49-0.98) as did exclusion of colon cancer cases that occurred within the first 2 years of follow-up (RR, 0.72; 95% CI, 0.51-1.00).



View larger version (18K):
[in this window]
[in a new window]
  		Figure 1. Multivariate RR of colon cancer according to dietary folate intake. RRs are adjusted for age (continuous), body mass index (quartiles), educational level (less than high school, high school, university), and quartiles of red meat consumption, total energy intake, and energy-adjusted intakes of saturated fat, methionine, vitamin B-6, ß-carotene, calcium, and cereal fiber. Solid black line, point estimates; dashed lines, 95% CIs.

 
We conducted stratified analyses to assess whether the inverse association of dietary folate intake with colon cancer risk was modified by caffeine intake or by smoking status and duration (Table 3). Because there were limited numbers of colon cancer cases in each category, we used tertiles of dietary folate intake. We found a statistically significant interaction between smoking and dietary folate intake in relation to colon cancer risk (Pinteraction = 0.03). Whereas risk of colon cancer decreased with increasing intakes of dietary folate among women who had smoked for 10 years or more during lifetime, women who had never smoked, and already had a lower risk, did not seem to benefit from a higher dietary folate intake. The association between intake of dietary folate and risk of colon cancer did not vary appreciably across levels of caffeine intake (Table 3).


View this table:
[in this window]
[in a new window]
  		Table 3. Multivariate RR of colon cancer according to dietary folate intake stratified by caffeine intake and cigarette smoking

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Our results, from a large population-based cohort of Swedish women, corroborate and extend the findings from previous studies, showing an inverse association between folate intake and risk of colon cancer (2). The observed inverse association of dietary folate intake with colon cancer risk is unlikely to be explained by other potentially beneficial constituents in folate-rich fruits and vegetables or by healthy behaviors related to such foods because the association remained after adjustment for consumption of fruits and vegetables.

Animal data have suggested that caffeine might act synergistically with folate deficiency to cause cytogenetic damage (8). On this basis, we hypothesized that an association between folate intake and risk of colon cancer might vary according to caffeine intake. In this study, however, we found no apparent modification of risk by caffeine intake. This lack of modification may be due to several reasons. For example, the folate intake in our study population may be sufficient to prevent folate deficiency or that only very high caffeine intake has a detrimental effect. Also, the animal data may not be applicable to humans.

In the current study, we noted a stronger inverse association between dietary folate intake and colon cancer risk among smokers than among never smokers. An interaction between pack-years smoked and folate intake was observed for lung cancer in a case-control study of past smokers (21). Furthermore, a recent case-control study (22) reported an interaction between smoking and polymorphisms in genes encoding enzymes involved in the folate-metabolic pathway in relation to risk of bladder cancer.

The major strengths of this study include its population-based nature, large sample size and large number of colorectal cancer cases, and practically complete follow-up through the Swedish Cancer registries (19). The prospective design precluded recall and selection biases. In Sweden, mandatory fortification of cereal-grain products with folic acid has not been introduced and use of vitamin supplements is less common than in the United States. Thus, we had the opportunity to evaluate dietary folate intake in relation to colorectal cancer risk in a population with a relatively low folate intake. The average daily intake of dietary folate was 211 µg among 129 participants who kept 28-day diet records. As comparison, the U.S. Recommended Dietary Allowance of 400 µg/d folate seems to be met by a large percentage of the U.S. adult population (23). It should be noted that the range of dietary folate intake in our study population was fairly narrow; yet, there was still a significant dose-response relationship between dietary folate intake and colon cancer risk.

The limitations of this study merit consideration. First, because diet was assessed through a self-administered food-frequency questionnaire and because we did not have information on the use of vitamin supplements at baseline, misclassification of total folate intake is of concern. Misclassification of folate intake, however, would be mostly random and tend to dilute any true association and, thus, could not explain our findings. In addition, exclusion of women who used vitamin supplements in 1997 did not materially change our results. Because of the observational design of this study, confounding because of unmeasured or imperfectly measured confounding variables cannot be ruled out.

In summary, findings from this large population-based prospective cohort study of women provide further epidemiologic evidence that increasing intake of folate may reduce the incidence of colon cancer. Results from this study also suggest that smokers might benefit most from a high folate intake. This finding is novel and requires confirmation in other studies.


   Footnotes
 
Grant support: Swedish Research Council/Longitudinal Studies, Swedish Cancer Foundation, and Swedish Foundation for International Cooperation in Research and Higher Education.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 8/ 3/04; revised 9/16/04; accepted 10/ 4/04.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511–9.[Abstract/Free Full Text]
  2. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132:2350–5S.
  3. Choi SW, Kim YI, Weitzel JN, Mason JB. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998;43:93–9.[Abstract/Free Full Text]
  4. Jacky PB, Beek B, Sutherland GR. Fragile sites in chromosomes: possible model for the study of spontaneous chromosome breakage. Science 1983;220:69–70.[Abstract/Free Full Text]
  5. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290–5.[Abstract/Free Full Text]
  6. Glover TW, Coyle-Morris J, Morgan R. Fragile sites: overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet Cytogenet 1986;19:141–50.[CrossRef][Medline]
  7. Yunis JJ, Soreng AL. Constitutive fragile sites and cancer. Science 1984;226:1199–204.[Abstract/Free Full Text]
  8. MacGregor JT, Schlegel R, Wehr CM, Alperin P, Ames BN. Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine. Proc Natl Acad Sci U S A 1990;87:9962–5.[Abstract/Free Full Text]
  9. Chen AT, Reidy JA, Annest JL, Welty TK, Zhou HG. Increased chromosome fragility as a consequence of blood folate levels, smoking status, and coffee consumption. Environ Mol Mutagen 1989;13:319–24.[Medline]
  10. Smith DF, MacGregor JT, Hiatt RA, et al. Micronucleated erythrocytes as an index of cytogenetic damage in humans: demographic and dietary factors associated with micronucleated erythrocytes in splenectomized subjects. Cancer Res 1990;50:5049–54.[Abstract/Free Full Text]
  11. Bailey LB. Folate status assessment. J Nutr 1990;120 Suppl 11:1508–11.
  12. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994;60:559–66.[Abstract/Free Full Text]
  13. Ulvik A, Evensen ET, Lien EA, et al. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 2001;101:246–54.[CrossRef][Medline]
  14. Kao-Shan CS, Fine RL, Whang-Peng J, Lee EC, Chabner BA. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res 1987;47:6278–82.[Abstract/Free Full Text]
  15. Chen AT, Reidy JA, Zhou XT. Smoking and chromosome breakage in low folic acid medium. Environ Mol Mutagen 1986;8:17.
  16. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83–133.[Abstract/Free Full Text]
  17. Bergström L, Kylberg E, Hagman U, Erikson H, Bruce Å. The food composition database KOST: the National Food Administration's Information System for nutritive values of food. Vår Föda 1991;43:439–47.
  18. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17–27.[Free Full Text]
  19. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiologica Oncol 1984;23:305–13.
  20. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551–61.[Medline]
  21. Shen H, Wei Q, Pillow PC, Amos CI, Hong WK, Spitz MR. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2003;12:980–6.[Abstract/Free Full Text]
  22. Lin J, Spitz MR, Wang Y, et al. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 2004;25:1639–47.[Abstract/Free Full Text]
  23. Bailey LB. Folate and vitamin B12 recommended intakes and status in the United States. Nutr Rev 2004;62:S14–21.[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Therapeutic Advances in GastroenterologyHome page
J. A. Abrams
Review: Chemoprevention of esophageal adenocarcinoma
Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18.
[Abstract] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A D. Smith, Y.-I. Kim, and H. Refsum
Is folic acid good for everyone?
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C.-F. Chiu, C.-H. Wang, C.-L. Wang, C.-C. Lin, N.-Y. Hsu, J.-R. Weng, and D.-T. Bau
A Novel Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Gastric Cancer Susceptibility in Taiwan
Ann. Surg. Oncol., February 1, 2008; 15(2): 514 - 518.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. J. Powers, M. H. Hill, M. Welfare, A. Spiers, W. Bal, J. Russell, Y. Duckworth, E. Gibney, E. A. Williams, and J. C. Mathers
Responses of Biomarkers of Folate and Riboflavin Status to Folate and Riboflavin Supplementation in Healthy and Colorectal Polyp Patients (The FAB2 Study)
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2128 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. Ishihara, T. Otani, M. Inoue, M. Iwasaki, S. Sasazuki, S. Tsugane, and for the Japan Public Health Center-based Prospecti
Low Intake of Vitamin B-6 Is Associated with Increased Risk of Colorectal Cancer in Japanese Men
J. Nutr., July 1, 2007; 137(7): 1808 - 1814.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. M. Welzel, H. A. Katki, L. C. Sakoda, A. A. Evans, W. T. London, G. Chen, S. O'Broin, F.-M. Shen, W.-Y. Lin, and K. A. McGlynn
Blood Folate Levels and Risk of Liver Damage and Hepatocellular Carcinoma in a Prospective High-Risk Cohort
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1279 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. Greenwald, D. Anderson, S. A Nelson, and P. R Taylor
Clinical trials of vitamin and mineral supplements for cancer prevention
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 314S - 317S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. de Vogel, M. van Engeland, M. Luchtenborg, A. P. de Bruine, G. M. J. M. Roemen, M. H. F. M. Lentjes, R. A. Goldbohm, P. A. van den Brandt, A. F. P. M. de Goeij, and M. P. Weijenberg
Dietary Folate and APC Mutations in Sporadic Colorectal Cancer
J. Nutr., December 1, 2006; 136(12): 3015 - 3021.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
B Van Guelpen, J Hultdin, I Johansson, G Hallmans, R Stenling, E Riboli, A Winkvist, and R Palmqvist
Low folate levels may protect against colorectal cancer
Gut, October 1, 2006; 55(10): 1461 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. C. Larsson, E. Giovannucci, and A. Wolk
Folate intake and stomach cancer incidence in a prospective cohort of Swedish women.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1409 - 1412.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. C. Larsson, N. Hakansson, E. Giovannucci, and A. Wolk
Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men.
J Natl Cancer Inst, March 15, 2006; 98(6): 407 - 413.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. M. Zhang, S. C. Moore, J. Lin, N. R. Cook, J. E. Manson, I-M. Lee, and J. E. Buring
Folate, Vitamin B6, Multivitamin Supplements, and Colorectal Cancer Risk in Women
Am. J. Epidemiol., January 15, 2006; 163(2): 108 - 115.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online